DOI: 10.1039/d3ay01562a ISSN: 1759-9660

A validated eco-friendly HPLC-FLD for analysis of the first approved antiviral remdesivir with other potential add-on therapies for COVID-19 in human plasma and pharmaceuticals

Asmaa M. Taha, Wafaa S. Hassan, Manal S. Elmasry, Rania A. Sayed
  • General Engineering
  • General Chemical Engineering
  • Analytical Chemistry

An HPLC-FLD method was proposed to determine remdesivir, hydroxychloroquine, and levofloxacin in their pure form and in human plasma, with high sensitivity and a wide linear range. Validation was done as per ICH and FDA guidelines, and the method greenness was evaluated.

More from our Archive